Table 4. Cardiac findings in untreated and treated SNX rats (series 2)

LV Weight/Body Weight Ratio (× 103)Nonperfused Area at Risk/LV AreaInfarcted Area/LV AreaInfarcted Area/Nonperfused Area at Risk
a Pair-fed and compared with untreated SNX rats in experiment 1.
Experiment 1
    SNX untreated pair-fed  rats (n = 8)2.46 ± 0.240.396 ± 0.0930.295 ± 0.0720.756 ± 0.093
    SNX + hydralazine/ nadolol (n = 8)2.35 ± 0.230.373 ± 0.0730.27 ± 0.0690.73 ± 0.094
    PaNSNSNSNS
Experiment 2
    SNX + moxonidine  (n = 7)2.52 ± 0.310.40 ± 0.050.282 ± 0.040.69 ± 0.08
    PaNSNSNSNS
Experiment 3
    SNX low-salt pair-fed rats  (n = 8)2.42 ± 0.270.355 ± 0.0790.267 ± 0.0480.772 ± 0.065
    SNX high-salt pair-fed rats  (n = 8)3.15 ± 0.380.337 ± 0.0790.264 ± 0.0680.788 ± 0.081
    P0.01NSNSNS